Recently, a small randomized pilot study has reported that this medication in addition to being safe and effective, would be able in patients with T1DM of recent onset to prolong endogenous insulin production thus suggesting the preservation of beta cell pancreatic function [4]. This evidence concerns the gene INS and type 1 diabetes mellitus.